Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >50 highly experienced drug discovery and industry professionals and built and operated multiple new successful companies; these companies have raised significant funds through Series B, IPO and an exit through a trade sale.
We are seeking an experienced and entrepreneurial Director / Senior Director, Medicinal Chemistry to lead small molecule drug discovery efforts across one of Ridgeline Discovery’s innovative portfolio companies.
The successful candidate will play a central scientific leadership role in advancing first-in-class therapeutic programs directed against novel intracellular targets. Working closely with biology, DMPK, computational chemistry and project leadership teams, this individual will drive medicinal chemistry strategy from hit identification through candidate nomination.
This position offers a unique opportunity to shape the direction of an emerging biotech company while contributing directly to innovative drug discovery programs with significant therapeutic potential.
